Mizuho’s Jared Holz on Novo Nordisk: There’s not much upside near-term

August 10, 2023

Jared Holz, Mizuho healthcare strategist, joins ‘Squawk Box’ to discuss Novo Nordisk’s quarterly earnings results, which hiked its outlook for 2023 after reporting a 30% increase in sales for the first half of the year, powered by strong demand for its weight loss drugs, and more.

Mizuho news from around the globe
Mizuho Global News
Back to top